SCHEMBL4103085

SCHEMBL4103085

COc1ccc(C)c2c1/C(=N/O)CC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
GAA P10253 2/20 0.42
GLA P06280 1/20 0.42
POLL Q9UGP5 1/20 0.40
EGFR P00533 1/20 0.36
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
MAPT P10636 2/20 0.33
ALOX15 P16050 1/20 0.33
MAPK1 P28482 1/20 0.33
ACHE P22303 1/20 0.33
DRD2 P14416 1/20 0.32
DRD1 P21728 1/20 0.32
LMNA P02545 1/20 0.32
ADRA1A P35348 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3411143 1.00 KDM4E (0.42) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL355639 0.88 KDM4E (0.55) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL355638 0.88 KDM4E (0.55) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL5461811 0.81 ALDH1A1 (0.47) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL5461808 0.81 ALDH1A1 (0.47) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL10664537 0.77 MAOA (0.47) KDM4EMAPTALOX15MAPK1NPC1
SCHEMBL10664533 0.77 MAOA (0.47) KDM4EMAPTALOX15MAPK1NPC1
SCHEMBL3410798 0.74 KDM4E (0.76) KDM4EALDH1A1HPGDGAAGLA
SCHEMBL659339 0.71 LMNA (0.45) KDM4EALDH1A1HPGDPOLLMAPT
SCHEMBL659340 0.71 LMNA (0.45) KDM4EALDH1A1HPGDPOLLMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183380-B2 2-aminoquinolines HOFFMANN-LA ROCHE INC. (US) 2012-05-22 US disclosed
US-20090227570-A1 2-AMINOQUINOLINES HOFFMANN-LA ROCHE, INC. 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227570-A1 2-AMINOQUINOLINES HTR5A, HTR2C, HTR2A KDM4E 1399/4885ALDH1A1 1203/4885HPGD 1948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.